Basic Information
YS Biopharma is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of next-generation vaccines and biologics for the prevention and treatment of infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulatory technology platform and a series of preventive and therapeutic biologics targeting rabies, hepatitis B, shingles, influenza, and coronaviruses.